Log in

Start free trial
Home 5 Clinical Diagnostics Insider 5 Diagnostics Pipeline: Scientists Ask Agency to Rescind Approval for Opioid Management Test

Diagnostics Pipeline: Scientists Ask Agency to Rescind Approval for Opioid Management Test

by | Aug 30, 2024 | Clinical Diagnostics Insider, FDA-dtet

Experts—including those in genetics and device regulation—say the AvertD assay did not predict risks of abuse ‘any better than chance’

A large group of prescription medication bottles sit on a table in front of a distraught man who is leaning on his hand as he sits at his dining room table. The image is photographed with a very shallow depth of field with the focus being on the pill bottles in the foreground, illustrating the concept of opioid abuse.
iStock, DNY59

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article

TRY FOR FREE